Tumor size can be an indicator of prognosis, but it is not the sole factor. Smaller tumors generally correlate with a better prognosis; however, other factors such as lymph node involvement, metastasis, and genetic markers of the tumor play a critical role in predicting patient outcomes. For example, in prostate cancer, the PSA level and Gleason score are also vital in assessing the prognosis.
